TLDR Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.
This case report details a rare occurrence of azathioprine-induced alopecia areata (AA) and severe bone marrow suppression in a 42-year-old man undergoing treatment for chronic urticaria. Azathioprine, an immunosuppressive drug, is typically associated with myelosuppression, but the sudden onset of AA is unusual. After 1 month of therapy, the patient experienced patchy hair loss and severe myelosuppression. Histopathology confirmed AA with lymphocytic infiltration around hair follicles. Discontinuation of azathioprine led to improved hematological parameters and hair regrowth, indicating a potential link between the drug and these adverse effects. This case underscores the need for careful monitoring of azathioprine's side effects due to the unpredictable nature of immunomodulatory therapy.
85 citations,
October 2012 in “Dermatologic Clinics” Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.
53 citations,
May 2011 in “Dermatologic therapy” Alopecia areata is a skin condition causing hair loss, and its exact cause is unknown, but it may involve biological mechanisms.
717 citations,
June 2010 in “Nature” Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.
36 citations,
July 2007 in “Journal of Investigative Dermatology” Certain HLA class II alleles increase or decrease the risk of alopecia areata.
61 citations,
March 2009 in “The Journal of the American Board of Family Medicine” Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.
January 2024 in “Journal der Deutschen Dermatologischen Gesellschaft” Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.
July 2023 in “IntechOpen eBooks” New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.
42 citations,
January 1998 in “BioDrugs” Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.
March 2022 in “Nepal Journal of Dermatology Venereology & Leprology” Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.
